Group 1 - The Tortoise Essential Energy Fund ETF (NYSE: TPZ) is identified as a good investment opportunity for those interested in actively managed funds focused on energy infrastructure [1] - The energy infrastructure industry is experiencing rapid growth, indicating a favorable market environment for investments in this sector [1] Group 2 - The fund has demonstrated solid performance, suggesting it may be a reliable choice for investors looking to capitalize on the energy sector [1]

  Calgary, Alberta / July 10, 2025 – TheNewswire - Credissential Inc. (“Credissential” or the “Company”) (CSE: WHIP) (OTC: IPTNF) (FSE: 9YZ) is pleased to announce that its wholly owned subsidiary, Antenna Transfer Inc. (“Antenna”), has entered into a binding exclusive license and platform agreement with Effective Acceleration Ventures Limited (“EAV”) for the deployment and use of the Antenna Platform (the “Platform”) by EAV. Antenna, operating under the domain Antennatransfer.io, is a proprietary quantum- ...

WALTHAM, Mass., July 10, 2025 /PRNewswire/ -- Veralto Corporation (NYSE: VLTO), a global leader in essential water and product quality solutions dedicated to Safeguarding the World's Most Vital Resources™, announced that it will webcast its second quarter 2025 earnings conference call on Tuesday, July 29, 2025, beginning at 8:30 a.m. ET. A registration link to the webcast and a link to the accompanying slide presentation will be available on the "Investors" section of Veralto's website, www.veralto.com, und ...

Core Insights - Byrna Technologies Inc. (NASDAQ: BYRN) has been a long-term investment for approximately 4½ years, indicating a commitment to the company despite market volatility [1] - The investment strategy combines fundamental analysis with momentum research, utilizing software to track market sentiment [1] - The focus is on identifying companies with a higher likelihood of surprising market expectations in the near term [1] Company Analysis - Byrna Technologies has experienced a rocky road over the years, suggesting challenges in its operational or market performance [1] - The investment approach aims to exploit discrepancies between market perceptions and actual outcomes, highlighting a strategic focus on potential undervaluation [1] Market Sentiment - The software developed by the analyst tracks levels of optimism and pessimism in stock prices, which is crucial for making informed investment decisions [1] - The strategy emphasizes the importance of understanding market sentiment to identify profitable investment opportunities [1]

德意志银行预计，通用动力二季度每股收益将超出市场共识预期6%，并可能上调全年业绩指引，推动 华尔街预期产生1-2%的正向修正。 诺斯罗普格鲁曼：估值偏高下调至"持有" 对于诺斯罗普格鲁曼，尽管二季度每股收益因培训业务剥离或超预期11%，但销售额及息税前利润可能 略低于市场预期。分析师担忧其当前溢价估值已无法匹配盈利增长轨迹，授标延迟、项目取消(如PTS- R、E-7)及ESS项目亏损等风险因素，可能导致公司下调全年销售及利润指引。 虽然B-21轰炸机和Sentinel导弹等长期增长引擎具备潜力，但其他业务板块的拖累削弱了估值支撑。德 意志银行将目标价从580美元下调至542美元，对应自由现金流收益率从4.75%微调至5%，仅预留7%上 行空间，故下调评级至"持有"。 德意志银行分析师斯科特.多伊施勒周二调整了对美国国防板块的判断，在第二季度财报季潜在波动来 临前，对三家军工企业作出评级变动：将通用动力(GD.US)公司评级由"持有"上调至"买入"，同时将诺 斯罗普格鲁曼(NOC.US)公司和BWX(BWXT.US)科技公司评级下调至"持有"。 该机构认为，大型国防股二季度业绩将呈现分化态势，部分企业面临业绩指 ...

Core Insights - SoFi Technologies, Inc. (SOFI) is focusing on its core strengths of scale and innovation to enhance profitability in a competitive fintech environment [1] Financial Performance - In Q1 2025, SoFi achieved a 20% year-over-year increase in net sales and a 217% surge in net income, indicating an efficient cost structure [2][7] - The company is pursuing growth initiatives to diversify revenue and enhance customer engagement, including a $2 billion extension of its Loan Platform Business agreement with Fortress Investment Group [2][7] Product Development - SoFi launched two new credit cards, the SoFi Everyday Cash Rewards Credit Card and the SoFi Essential Credit Card, which have strengthened its position in consumer finance and increased user retention [3] Competitive Landscape - SoFi faces significant competition from fintech companies like Block and Upstart, which are also leveraging innovation and scale to drive growth [4][5] - Block is expanding its ecosystem through consumer payments and small-business lending, while Upstart is utilizing AI for credit risk assessment and has entered new lending markets [5] Stock Performance and Valuation - SoFi's stock has increased by 25% year-to-date, outperforming the industry average of 4% [6] - The company trades at a forward price-to-earnings ratio of 48.88, significantly higher than the industry's 21.62, indicating a potential overvaluation [8]

SENTI-202 Program Highlights - SENTI-202 is a first-in-class off-the-shelf Logic-Gated selective CD33 OR FLT3 NOT EMCN CAR NK cell therapy targeting AML [4, 5, 52] - The therapy is designed to selectively kill both AML blasts and LSCs while protecting healthy HSPCs [15, 52] - Preliminary Phase 1 trial data shows positive efficacy in R/R AML [5] Clinical Trial & Patient Data - The Phase 1 trial (SENTI-202-101) enrolled heavily pretreated R/R AML patients with poor prognosis [18, 52] - The study identified a preliminary Recommended Phase 2 Dose (RP2D) [20, 22, 52] - The opening dose cohort was anticipated to be biologically active [18, 22] - The median time from AML diagnosis to trial entry was less than 1 year [25] - Patients had received a median of 2 prior lines of therapy [27] Safety & Tolerability - SENTI-202 was generally well-tolerated in R/R AML patients [30, 52] - Most frequent Grade 3+ AEs were hematologic and consistent with R/R AML patients receiving lymphodepletion [29, 52] - The Maximum Tolerated Dose (MTD) was not reached, and the preliminary RP2D was identified as 1.5 x 10^9 cells/dose x 3 weekly doses/28 days [52] Efficacy & Response - Across all patients, the Overall Response Rate (ORR) was 71% (5/7) and the composite Complete Remission (cCR) rate was 57% (4/7) [33, 57] - In the preliminary RP2D cohort, the cCR rate was 67% (2/3) [33, 57] - All cCR patients (4/4) achieved MRD- status as assessed per local standard of care [33, 57] - All cCR patients maintained morphologic remission with the longest follow-up of 8+ months [57]

Athletes can shop hundreds of deals from top brands July 7–10, online and via the DICK'S mobile appPITTSBURGH, July 2, 2025 /PRNewswire/ -- DICK'S Sporting Goods (NYSE: DKS) today announced DICK'S Deal Days, a four-day savings event running Monday, July 7 through Thursday, July 10. Timed to peak summer activity, travel and youth sports season, DICK'S Deal Days is the brand's biggest sale of the summer, with new deals dropping daily.Whether shopping online at DICKS.com or through the DICK'S mobile app, athle ...

MALTA, N.Y., July 02, 2025 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call on Tuesday, August 5, 2025, at 8:30 a.m. ET following the release of the company’s second quarter 2025 financial results. Conference Call and Webcast Information The company will host a conference call with the financial community on Tuesday, August 5, 2025, at 8:30 a.m. ET. Interested parties may join the scheduled conference call by registering here. The company’s financial resu ...

Core Insights - Senti Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation cell and gene therapies using its proprietary Gene Circuit platform [2][3] - The company's lead program, SENTI-202, is a first-in-class CAR NK cell therapy targeting hematologic malignancies, currently in a Phase 1 clinical trial with positive preliminary data [3] - SENTI-202 has received Orphan Drug Designation from the FDA for treating relapsed/refractory hematologic malignancies, including AML [3] Company Overview - Senti Bio aims to create new medicines for patients with incurable diseases by engineering Gene Circuits that can precisely target and kill cancer cells while sparing healthy cells [5] - The company's pipeline includes cell therapies designed to address challenging liquid and solid tumor indications, with Gene Circuits shown to work in both NK and T cells [5] - Senti Bio is also exploring the application of Gene Circuits in other diseases beyond oncology through partnerships [5]